Innervated artificial skin
The present invention provides, in some embodiments, multi-layer silk compositions including a first layer comprising silk fibroin and keratinocytes, a second layer comprising silk fibroin and fibroblasts, a third layer comprising silk fibroin and adipocytes, and a plurality of nervous system cells, wherein at least some of the plurality of nervous system cells span at least two layers, and methods of making and using the same. In some embodiments, provided methods and compositions further include immune cells and/or endothelial cells.
1. A multi-layer silk composition comprising
a first layer comprising silk fibroin and keratinocytes;
a second layer comprising silk fibroin and fibroblasts;
a third layer comprising silk fibroin and adipocytes; and
a plurality of nervous system cells,
wherein at least some of the plurality of nervous system cells span at least two layers.
2. The composition of claim 1 , wherein all of the cells in each of the first, second and third layers are human cells.
3. The composition of claim 2 , wherein the human cells are primary cells or cell lines.
4. The composition of claim 1 , wherein the nervous systems cells comprise at least one of neurons, glia, and neural stem cells.
5. The composition of claim 1 , wherein at least a plurality of the nervous system cells are functional.
6. The composition of claim 1 , further comprising a plurality of at least one type of immune cells.
7. The composition of claim 6 , wherein the at least one type of immune cells includes macrophages.
8. The composition of claim 1 , further comprising a plurality of at least one type of endothelial cell.
9. The composition of claim 8 , wherein the endothelial cells comprise a monolayer.
10. The composition of claim 1 , further comprising an electrical device that is functionally connected to at least some of the plurality nervous system cells.
11. The composition of claim 10 , wherein activation of the electrical device results in the firing of one or more neurons.
12. The composition of claim 10 , wherein the electrical device comprises at least one electrode.
13. The composition of claim 10 , wherein the electrical device comprises silk fibroin.
14. The composition of claim 1 , further comprising at least one of collagen, laminin, fibronectin, hyaluronic acid, fibrinogen, sulfated glycosaminoglycans, and/or one or more growth factors, in at least one layer.
15. The composition of claim 14 , wherein the one or more growth factors comprise epidermal growth factor, fibroblast growth factor, nerve growth factor, platelet-derived growth actor, insulin-like growth factor, or tumor necrosis factor-β, and combinations thereof.
16. The composition of claim 1 , wherein at least one layer is exposed to an air-liquid interface.
17. The composition of claim 1 , wherein the third layer comprises lipoaspirate.
18. A method of making a multi-layer silk composition comprising
providing a first layer comprising silk fibroin and keratinocytes;
providing a second layer comprising silk fibroin and fibroblasts;
providing a third layer comprising silk fibroin and adipocytes;
providing a plurality of nervous system cells; and
associating the first layer, second layer, third layer, and plurality of nervous system cells to form a multi-layer silk composition, wherein at least some of the plurality of nervous system cells span at least two layers.
19. A method comprising
a) providing a multi-layer silk composition comprising a first layer, a second layer, a third layer, and a plurality of nervous system cells, the first layer comprising silk fibroin and keratinocytes, the second layer comprising silk fibroin and fibroblasts, the third layer comprising silk fibroin and adipocytes, wherein at least some of the plurality of nervous system cells span at least two layers, wherein at least some of the cells in the composition are cancer cells;
b) exposing the composition to one or more therapeutic agents and/or inflammatory agents; and
c) characterizing the response of the cells in the composition to the one or more therapeutic agents.
20. The method of claim 19 , wherein the one or more therapeutics agents comprise at least one cancer therapeutic agent.